세계의 혈관내 동맥류 수복 기기 시장 규모 : 제품 유형별, 동맥류 유형별, 최종 사용자별, 지역별, 범위 및 예측

Endovascular Aneurysm Repair Devices Market Size And Forecast

Endovascular Aneurysm Repair Devices Market size was valued at USD 2647 Million in 2023 and is projected to reach USD 4360 Million by 2030 , growing at a CAGR of 4.9% during the forecast period 2024 to 2030. The Endovascular Aneurysm Repair Devices Market encompasses a range of medical devices and technologies designed for the minimally invasive treatment of aneurysms, particularly within the vascular system. These devices are utilized in endovascular procedures to repair weakened areas of blood vessels, thereby reducing the risk of rupture and potentially life-threatening complications.

Endovascular aneurysm repair (EVAR) devices include stent grafts, catheters, guidewires, and other related tools used to reinforce and stabilize the affected blood vessel without the need for open surgery.

Global Endovascular Aneurysm Repair Devices Market Drivers

The market drivers for the Endovascular Aneurysm Repair Devices Market can be influenced by various factors. These may include:

Prevalence of Aortic Aneurysms:

One major factor propelling the global market for EVAR devices is the rising incidence of aortic aneurysms. Effective treatment options are required since the incidence of aortic aneurysms, especially abdominal aortic aneurysms (AAA), is increasing due to changes in lifestyle and aging of the population.

Technological developments:

Technological developments in endovascular procedures and equipment have resulted in an expansion of treatment options for aortic aneurysms. The safety and effectiveness of EVAR operations have been enhanced by innovations like stent grafts, delivery methods, and imaging technologies, which have propelled market expansion.

Minimally Invasive Nature:

When EVAR procedures are performed instead of open surgery, they are less invasive and come with advantages like shorter hospital stays, quicker recovery times, and lower rates of morbidity and death. The demand for EVAR devices is being driven by patients' and doctors' increased preference for minimally invasive procedures.

Growing Senior Population:

As people age, they become more vulnerable to aortic aneurysms, which increases the need for EVAR devices. Growing worldwide, especially in developed nations, is the aging population, which raises the need for efficient aortic aneurysm treatment alternatives and propels market expansion.

Government Initiatives and Healthcare Reforms:

The adoption of EVAR devices is being driven by government initiatives aimed at enhancing the healthcare system and expanding access to cutting-edge medical treatments. Market expansion is also facilitated by reimbursement guidelines and healthcare reforms that encourage endovascular procedures.

Campaigns for Awareness and Screening Programs:

By driving up patient numbers and demand for EVAR treatments, initiatives to increase public knowledge of aortic aneurysms and the value of early detection through screening programs support market expansion.

Partnerships and Collaborations:

Research centers, medical device manufacturers, and healthcare providers work together to develop cutting-edge EVAR technology by promoting innovation. By utilizing complementary capabilities and resources, strategic partnerships also aid in market expansion.

Expansion in Emerging Markets:

Areas like Asia-Pacific, Latin America, and the Middle East offer substantial prospects for market growth due to the developing healthcare infrastructure in these countries, as well as rising disposable income and rising awareness of cutting-edge medical treatments.

Global Endovascular Aneurysm Repair Devices Market Restraints

Several factors can act as restraints or challenges for the Endovascular Aneurysm Repair Devices Market. These may include:

Exorbitant Cost of EVAR Procedures:

The price of EVAR procedures can be high, taking into account the devices, the hospital stay, and the aftercare. Because of its high cost, EVAR therapies may not be as widely available, especially in areas with tight healthcare budgets or low reimbursement.

Problems with Long-Term Sturdiness Concerns:

Although EVAR technology has advanced, questions still exist about its long-term viability and possible side effects such endoleaks, graft migration, and infections from the device. These elements may have an impact on patient outcomes and discourage doctors and patients from choosing EVAR over open surgery.

Scarce Skilled Interventionalists:

To execute EVAR treatments, one needs specific knowledge and training in either vascular surgery or interventional radiology. The scarcity of trained interventionists, especially in remote or underprivileged locations, can limit patient access to EVAR therapies and impede the expansion of the market.

Regulatory Difficulties and Approval Delays:

EVAR device regulatory approval can be obtained through a protracted and intricate process that includes stringent clinical trials and regulatory filings. Market entry and innovation might be hindered by delays in getting approvals for new products or modifications to current ones, which can slow down the growth of the market.

Risk of Adverse Events and Reinterventions:

Although endoscopic vein grafting (EVAR) treatments are typically less invasive than open surgery, there is always a chance of problems including endoleak or graft failure. Reinterventions may be necessary to address these issues, which could raise healthcare expenditures and negatively affect patient quality of life. As a result, patients may be reluctant to use EVAR treatments.

Limited Reimbursement Coverage:

In certain healthcare systems, patient access may be restricted by rigorous eligibility requirements or by reimbursement policies that do not sufficiently cover the expenses of EVAR procedures. Market expansion may be hampered by inadequate reimbursement, especially in areas where out-of-pocket costs are high.

Alternative Therapies:

For some patient populations, alternative therapies for aortic aneurysms, such as open surgical repair or watchful waiting along with imaging surveillance, are still appropriate. These substitutes' accessibility may have an impact on EVAR device adoption as well as market expansion.

Economic Uncertainty and Market Volatility:

Investment choices and healthcare spending can be impacted by market uncertainty and volatility brought about by economic downturns, geopolitical unrest, and changes in healthcare policy. Market dynamics may be impacted by economic issues that affect patients' ability to pay for EVAR treatments and hospitals' purchasing decisions.

Global Endovascular Aneurysm Repair Devices Market Segmentation Analysis

The Global Endovascular Aneurysm Repair Devices Market is segmented based on Product Type, Aneurysm Type, End User And Geography.

Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts:
• Stent grafts designed specifically for the endovascular repair of aortic aneurysms, providing a minimally invasive alternative to open surgery.
• Catheters:
• Flexible tubes used for various diagnostic and interventional procedures, including guiding other medical devices such as stent grafts during endovascular aneurysm repair.
• Guidewires:
• Thin, flexible wires used to guide catheters and other medical devices through the blood vessels to reach the treatment site accurately.
• Endovascular Aneurysm Repair (EVAR) Systems:
• Comprehensive systems including devices such as stent grafts, catheters, and guidewires, designed to facilitate the minimally invasive repair of aortic aneurysms.

Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA):
• Aneurysms occurring in the abdominal portion of the aorta, which can be treated using various endovascular techniques.
• Thoracic Aortic Aneurysms (TAA):
• Aneurysms affecting the thoracic portion of the aorta, often requiring specialized stent grafts for endovascular repair.
• Peripheral Aneurysms:
• Aneurysms found in peripheral arteries outside of the aorta, requiring tailored endovascular approaches for treatment.

Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals:
• Facilities equipped with the infrastructure and expertise to provide comprehensive medical care, including the diagnosis and treatment of aortic aneurysms using endovascular devices.
• Ambulatory Surgical Centers:
• Outpatient facilities specializing in performing surgical procedures, including minimally invasive endovascular aneurysm repair, with shorter recovery times compared to traditional hospitals.
• Specialty Clinics:
• Clinics focusing on specific medical specialties, such as vascular surgery or interventional radiology, providing targeted care for patients requiring endovascular treatment for aneurysms.

Endovascular Aneurysm Repair Devices Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Key Players

• The major players in the Endovascular Aneurysm Repair Devices Market are:
• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton Dickinson and Company
• Cardinal Health Inc.
• Endologix Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• L. Gore & Associates Inc.
• Getinge AB

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts
• Catheters
• Guidewires
• Endovascular Aneurysm Repair (EVAR) Systems

5. Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA)
• Thoracic Aortic Aneurysms (TAA)
• Peripheral Aneurysms

6. Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health Inc.
• Endologix, Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Getinge AB

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References